Aktuelle News

Ovesco Messestand

Conference of DGVS and DGAV 2020

Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Header_AWC_2

EMR+: pilot study evaluating data from the first in human clinical cases shows 100 % R0-resection rate and no severe adverse events

The novel EMR+ technique uses an external additional working channel (AWC®) allowing for tissue retraction
OVE_Header_Webinar_Resec_Praxisnah_2020-09-14

DEGEA Webinar: FTRD® & RESECT+ | Innovative Resektionstechniken praxisnah erklärt – jetzt online verfügbar

In Kooperation mit der DEGEA fand am 21. Oktober 2020 das Webinar „FTRD® & RESECT+
OVE_Header_Webinar_Resec_Praxisnah_2020-09-14

DEGEA Webinar Live* „FTRD® & RESECT+ | Innovative Resektionstechniken praxisnah erklärt“ am 21. Oktober 2020, 18:00 – 19:30

Ovesco sponsert dieses Livestream-Webinar zu innovativen Resektionstechniken mit Einblicken und Tipps aus der Pflege. Das
Header_HemoPill_Pressemitteilung_komp

Pressemitteilung | Ein schluckbares Mini-Labor für die Notfalldiagnostik im Magen

Die Magenblutung ist ein lebensbedrohlicher Notfall. Eine kontaktlose Erkennung ist aktuell auch bei COVID-19-(positiven) Patienten

Weitere News im Überblick

Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
The novel EMR+ technique uses an external additional working channel (AWC®) allowing for tissue retraction
In Kooperation mit der DEGEA fand am 21. Oktober 2020 das Webinar „FTRD® & RESECT+
Ovesco sponsert dieses Livestream-Webinar zu innovativen Resektionstechniken mit Einblicken und Tipps aus der Pflege. Das
Die Magenblutung ist ein lebensbedrohlicher Notfall. Eine kontaktlose Erkennung ist aktuell auch bei COVID-19-(positiven) Patienten
Am Donnerstagabend trafen sich im Foyer der Ovesco Endoscopy AG 50 Gäste zu der von
Die erste DGE-BV Online Endoskopie-Sitzung mit dem Thema „Diagnostik 2020 – Künstliche Intelligenz und Sensorik“
OTSC application is recommended for esophageal iatrogenic perforation > 10 mm, for gastric iatrogenic perforations
A meta-analysis comprising 18 studies with overall 730 patients with difficult gastrointestinal lesions showed a
A cost analysis based on mathematic modelling determined the average cost of repeating standard treatment
Ovesco Endoscopy awarded TOP 10 MEDICAL DIAGNOSTICS Solution Providers 2020 Ovesco Endoscopy has made it
Prof. Alexander Meining, Interventionelle und Experimentelle Endoskopie (InExEn), Innere Medizin II, Universitätsklinikum Würzburg, erhielt für
Expand your horizon on resection techniques in endoluminal surgery. This was the underlying topic of
stentfix OTSC was used in five complex cases who already had experienced stent migration and
92 patients with 117 non-acute full-thickness gastrointestinal defects (65 fistulas, 52 leaks) underwent OTSC therapy.
The novel submucosal injection agent LiftUp was successfully used in a first clinical case series
The patient had experienced esophageal perforation due to bougienage with a through-the-scope balloon, which led
Ovesco is proud to announce that the gastroduodenal FTRD® has been cleared for marketing by
Conference report of the Digestive Disease Week (DDW) 2020 FTRD® System: EFTR enables new therapeutic
106 patients with perforated peptic ulcer were treated with OTSC (n = 26) or conservative
16 patients with rectovaginal fistulas, 13 of those having undergone previous surgical interventions, were treated
In lesions > 2 cm, EMR+ outdoes its advantages: comparative trial demonstrates en-bloc resection rate
Because of its tissue apposition capabilities and easy en face application, OTSC is used as
In 7/10 patients with enterocutaneous fistula, OTSC application resulted in complete fistula closure. While NSQIP
Conference Report of the American College of Gastroenterology (ACG) 2019: OTSC®: Besides a RCT showing
„Alle reden nur davon – Ovesco macht`s“ – die Vertriebs-Fahrzeuge der Ovesco-Flotte fahren dank ARKTIK
In 40 patients with rectal neuroendocrine tumors (NETs), EFTR resulted in 100 % macroscopically and
Ovesco konnte in den vergangenen Jahren ein großes Umsatz- und Mitarbeiterwachstum verzeichnen. Unter 12.500 bundesweit
In 96 patients with complex anorectal fistulas, OTSC Proctology application lead to an overall healing
Ovesco is proud to announce that LiftUp® has received market approval in Australia and New
Ovesco Endoscopy AG spendet 3.314,05 € an die Stiftung „Hilfe für kranke Kinder“ der Uni-Kinderklinik
„Alle reden nur davon – Ovesco macht`s“ – die Vertriebs-Fahrzeuge der Ovesco-Flotte fahren dank ARKTIK
Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superiority over conventional
A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeting shows the
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
In 156 patients with histologic evidence of adenocarcinoma, EFTR was technically successful in 92.3 %
Ovesco Endoscopy is pleased to announce that the stentfix OTSC® System Set has received market
The Gastrointestinal Endoscopy Editorial Board chooses resection techniques namely EMR/submucosal dissection and full-thickness resection as
EFTR in 30 patients with recurrent / residual colorectal neoplasia led to R0 resection in
Unter Teilnahme geladener Gäste aus Politik, Medizin und Wirtschaft übergibt das Tübinger Medizintechnikunternehmen den Neubau
The novel EMR+ technique uses an external additional working channel (AWC®) and a poloxamer agent
When compared to fistulectomy and primary sphincter reconstruction, the OTSC Proctology showed comparable results (93
Irren ist menschlich – helfen auch! Aufgrund einer verpassten Messestand-Anmeldung bei dem Viszeralmedizin-Kongress der DGVS
In 50 patients with complex benign esophageal stenoses, endoscopic bougienage with the BougieCap was successful
Für die Ovesco Endoscopy AG zählt die Produktinnovation zu den Kernkompetenzen. prognos und das F.A.Z-Institut
Digestive Disease Week – DDW 2019: – National and international multicenter studies confirm that the
Anlässlich des 1. Familientages im neuen Gebäude spenden die ovesco Endoscopy AG und die novineon
German Coloproctology-Congress of the German Society for Coloproctology (Deutsche Gesellschaft für Koloproktologie – DGK) together
93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with
Ovesco strengthens research on diagnostic devices with substantial funding The German Federal Ministry of Education
In lesions of 3 cm, EMR+ reaches its best discriminatory power: R0 resection rate of
Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achieved
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together with the
Nach dem Umzug in ihre neue Firmenzentrale im Technologiepark Tübingen Anfang Mai, nimmt die Ovesco
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %
Die ovesco Endoscopy AG ist zum 29. April 2019 in ihre neue Unternehmenszentrale umgezogen und
Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resection
Ovesco is proud to announce that both the OTSC® System and the remOVE System including
6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic resection in all
EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a
96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower
Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success
Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurrence/relapse of previous endoscopic
Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA
OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical success rate of
Stuttgart, 11. Dezember 2018 – Drei Tübinger Medizintechnik-Unternehmen erhalten den familyNET-Award „Familienfreundliches Unternehmen“. Ausgezeichnet wurden
OTSC use decreased the rebleeding rate in high-risk (RS ≥ 8) patients with statistical significance
Conference Report of the United European Gastroenterology Week (UEGW) 2018: RESECT+: additional working channel (AWC®)
All 19 patients were treated successfully with the OTSC System. In 74 % of cases,
Multicenter study shows high technical success rate and significant improvement of dysphagia symptoms. B Walter
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
100 % primary hemostasis rate and improved management of rebleeding with OTSC® used as first
87.9 % R0-resection of non-lifting and submucosal colonic lesions with FTRD® Aepli P et al.,
66.6 % of patients with leaking from the “J” of the tip of an ileo-anal
Dr Wedi received the DGVS endoscopy research award for the FLETRock study, a multi-centric study
Bauder M et al., Department of Gastroenterology and Oncology, Ludwigsburg Hospital, Ludwigsburg, Germany, presented a
A systematic literature review evaluating efficacy and safety of the OTSC System in the management
Kobara H and colleagues, Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa,
Raithel M and colleagues, Department of Medicine II, University Erlangen, Germany presented data from three
As part of the “Tübinger Klimaschutzpakt” the Ovesco Endoscopy AG contributes to climate protection and
Ovesco is proud to announce that the OTSC® System including the OTSC® Anchor and the
Mizrahi I and colleagues, Digestive Disease Institute, Cleveland Clinic Florida, Weston, FL, USA, reported their
Honegger C and colleagues, Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, presented
Gianfranco G. et al., Interventional Endoscopy Unit, Hospital Privé des Peupliers, Paris, France, presented a
OTSC has long been described in the scientific literature as a highly effective device for
Valli and colleagues, Division of Gastroenterology and Hepatology, Zurich University Hospital, Switzerland, reported about their
Ovesco welcomes following new distribution partners: Biogene Pharma Limited, a leading distributor of Medical Device
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) together with the learned
Prof Dr Alexander Meining, Department of Interventional and Experimental Endoscopy, University Hospital Ulm, received the
Within the scope of the Annual Meeting of the Chilean – Germany Chamber of Commerce
A. Braun and H. Dawson, Gastroenterology and Endoscopy, SRO Langenthal, Switzerland and Institute of Pathology,
The 48th Conference of the German Society for Endoscopy and Imaging Procedures (Deutsche Gesellschaft für
El Douaihy Y et al., Department of Internal Medicine, Staten Island University Hospital – Northwell
PD Dr Schmidt, Department of Inner Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectiology, University Hospital
J Brandler and colleagues, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, performed a
Ovesco is proud to announce the launch of the BougieCap. A new method for the
Ovesco announces that the remOVE System has been cleared by the US Food and Drug
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
One of Germany’s first innovation awards, the state innovation award Baden-Württemberg – Dr.-Rudolf-Eberle-Prize – has
Ovesco is proud to announce that OTSC has received market approval in Peru. The product
Mangiafico S et al., Azienda Ospedaliero, University of Modena, Italy, presented at the 25th UEG
Chan SM and Lau JYW, Prince of Wales Hospital, The Chinese University of Hong Kong,
Ovesco is proud to announce that OTSC has received market approval in Taiwan. The product
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Devan Kizhakee – new Commercial Director MEA, Australasia Devan Kizhakee Kurichyath has an extensive experience
In July Ovesco Endoscopy celebrated their groundbreaking ceremony for its new corporate headquarters for management,
Schmidt A, Beyna T, Schumacher B et al., affiliated to different German hospitals (Ludwigsburg, Freiburg,
Business news magazine brand eins rates Ovesco Endoscopy among the most innovative German companies. The
Innovative BougieCap and resection method developed in cooperation with Ovesco, randomized controlled study shows significant
Tübingen, July 19, 2017 – Groundbreaking ceremony marks beginning of construction Das Tübinger Medizintechnikunternehmen errichtet
Ovesco publishes an updated OTSC® update containing further relevant publications on research conducted with the
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Xiao X and Lau JY, Department of Surgery, Chinese University of Hong Kong, Hong Kong,
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Within the scope of the Annual Meeting of the British Society for Gastroenterology (BSG) from
R Manta et al., Niguarda-Ca Granda Hospital, Milan, Nuovo S. Agostino Hospital, Modena, Nuovo Regina
Within the scope of the DGE-BV / Endoscopy Live Congress in Berlin, the afternoon symposium
Dr. Malay Sharma from North India received the audiovisual award for the use of the
Dr. Schmidt, Department of Inner Medicine, Gastroenterology, Hemato-Oncology, Diabetology and Infectiology, Ludwigsburg Hospital, Germany, received
The internet platform Endoscopy Campus is providing the latest information about endoscopy. Together with DGVS
HJ Richter-Schrag and colleagues, Center of Interdisciplinary Gastrointestinal Endoscopy and Department of General and Visceral